IO

Analytical Biosciences Named Finalist in IDC's Inaugural Best in Future of Digital Infrastructure North America Awards

Retrieved on: 
Monday, September 20, 2021

SAN FRANCISCO, Sept. 20, 2021 /PRNewswire/ -- Analytical Biosciencestoday announced it has been named a finalist in the inaugural IDC Future Enterprise Best in Future of Digital Infrastructure North America Awards in the Cloud-Centric Computing category.

Key Points: 
  • SAN FRANCISCO, Sept. 20, 2021 /PRNewswire/ -- Analytical Biosciencestoday announced it has been named a finalist in the inaugural IDC Future Enterprise Best in Future of Digital Infrastructure North America Awards in the Cloud-Centric Computing category.
  • "We were overwhelmed by the number of thoughtful and strategic initiatives submitted and congratulate all the finalists named in our inaugural IDC Future Enterprise Best in Future of Digital Infrastructure North American Awards program," said Mary Johnston Turner, Research Vice President for the Future of Digital Infrastructure Agenda research efforts at IDC.
  • "The finalists have effectively used digital infrastructure across on-prem, edge and public cloud platforms to transform their most important business processes and to launch new digital business innovations.
  • With their cell data and modalities of data growing extra-exponentially, Analytical Biosciences looked for a way to accelerate discovery.

OSE Immunotherapeutics Presented Positive Final Results of Tedopi® Phase 3 Clinical Trial in Secondary Resistant Non-Small Cell Lung Cancer Patients at the European Society for Medical Oncology (ESMO) Virtual Congress 2021

Retrieved on: 
Monday, September 20, 2021

Applying the 2020 SITC(2) guidelines defining resistance categories for PD-1/PD-L1 checkpoint inhibitors to our trial, developed while this trial was ongoing, suggest there is great potential for Tedopi in patients with secondary resistance(3).

Key Points: 
  • Applying the 2020 SITC(2) guidelines defining resistance categories for PD-1/PD-L1 checkpoint inhibitors to our trial, developed while this trial was ongoing, suggest there is great potential for Tedopi in patients with secondary resistance(3).
  • Therefore, we are very pleased to share such very promising results demonstrating the substantial benefits of Tedopi for NSCLC patients with secondary resistance to anti-PD-1 treatments, a hard to treat patient population with high medical need.
  • The Tedopi treatment was compared to docetaxel or pemetrexed chemotherapy (CT) treatments in this patient population, with overall survival as the primary endpoint of the trial.
  • A good tolerance profile of Tedopi with fewer Severe Adverse Events (Tedopi 38% vs SoC 68%, p

DDN and Tintri Launch IntelliFlash High Performance Enterprise NVMe and Hybrid Storage with Built-In AI and Multiprotocol Data Services

Retrieved on: 
Wednesday, September 15, 2021

The new IntelliFlash N-Series systems and enhancements to the IntelliFlash H-Series hybrid systems greatly reduce cost and complexity by simplifying business processes and consolidating all enterprise workloads.

Key Points: 
  • The new IntelliFlash N-Series systems and enhancements to the IntelliFlash H-Series hybrid systems greatly reduce cost and complexity by simplifying business processes and consolidating all enterprise workloads.
  • IntelliFlash customers benefit from the industry's most mature and proven NVMe platform from DDN, with the performance, scale and reliability required by modern applications.
  • With this release, existing IntelliFlash customers can also benefit from performance enhancements that further improve latency and throughput particularly for file services.
  • DDN provides its enterprise customers with themost flexible, efficient and reliable data storage solutions for on-premises and multi-cloud environments at any scale.

Play-to-earn Blockchain Game Starchi Wins Grant from Polygon Foundation

Retrieved on: 
Tuesday, September 14, 2021

Starchi is a purposeful game characterized by adoptable digital pets called Starchis that need to be raised, fed and entertained in a virtual environment.

Key Points: 
  • Starchi is a purposeful game characterized by adoptable digital pets called Starchis that need to be raised, fed and entertained in a virtual environment.
  • Within the game, Starchi Collectors are tasked with acquiring and nurturing Starchis from infancy to adulthood.
  • Starchi operates as a dual token economy with Starters START token ($START) and Starchi Liquid Luck token ($ELIXIR).
  • Collectors can begin their Starchi journey here https://starchi.gg/ and for more details regarding Starters Starchi game, future Collectors may visit https://starter.xyz/ .

BeyondSpring Announces Second Quarter 2021 Financial Results and Provides a Corporate Update

Retrieved on: 
Friday, September 10, 2021

NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the Company or BeyondSpring) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced its financial results for the second quarter ended June 30, 2021 and provided an update on recent corporate events.

Key Points: 
  • NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the Company or BeyondSpring) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced its financial results for the second quarter ended June 30, 2021 and provided an update on recent corporate events.
  • Research and development (R&D) expenses were $11.3million for the quarter ended June 30, 2021, compared to $11.0million for the quarter ended June 30, 2020.
  • General and administrative (G&A) expenses were $9.0million for the quarter ended June 30, 2021, compared to $2.6million for the quarter ended June 30, 2020.
  • Net loss attributable to the Company was $19.3million for the quarter ended June 30, 2021, compared to $12.8million for the quarter ended June 30, 2020.

ION announces third phase of Mid North Sea High 3D multi-client program

Retrieved on: 
Thursday, September 9, 2021

HOUSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- ION Geophysical Corporation (NYSE: IO) today announced a third, fully underwritten phase of the Companys Mid North Sea High 3D new acquisition multi-client program.

Key Points: 
  • HOUSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- ION Geophysical Corporation (NYSE: IO) today announced a third, fully underwritten phase of the Companys Mid North Sea High 3D new acquisition multi-client program.
  • The Mid North Sea High program covers one of the few remaining underexplored areas offshore the UK, where relatively low development costs close to shore make it attractive for future investment.
  • Adjacent to the initial phase, the survey location fills a gap in existing subsurface coverage and is strategically important to expanding IONs regional footprint.
  • Data collection of the ~700 sq km industry-supported survey is expected to occur from mid-September until late October.

Starter to Host Launch of DeFi Token $CUEX

Retrieved on: 
Thursday, September 9, 2021

Starter will oversee the trading and staking of $CUEX and support their goal to change the DeFi industry.

Key Points: 
  • Starter will oversee the trading and staking of $CUEX and support their goal to change the DeFi industry.
  • CUEX operates under the CUE Protocol team and is CUE protocols entry into the DeFi world.
  • CUEX is another of Starters highly sought after IDOs, handpicked by the Starter team and presented to the Starter community.
  • Starter consists of four separate branches: venture arm Starter.capital, decentralized launchpad Starter.xyz, decentralized exchange StarterSwap.xyz, and token vesting and liquidity locking StartVesting.xyz.

MiRus Receives FDA 510(K) Clearance For The Lowest Profile and Best-in-class Expandable Lumbar Interbody

Retrieved on: 
Tuesday, August 31, 2021

IO Expandable Lumbar Interbody powered by the MoRe Expansion Engine offers the lowest profile interbody on the market.

Key Points: 
  • IO Expandable Lumbar Interbody powered by the MoRe Expansion Engine offers the lowest profile interbody on the market.
  • The IO Expandable Lumbar Interbody can be utilized in both PLIF and TLIF procedures.
  • It features the lowest insertion profile (4mm) and greatest expansion (18mm) and lordosis (24) in a single implant of any expandable interbody on the market.
  • The upcoming launch of the IO Expandable Lumbar Interbody will meet the significant demand of our surgeons and distribution channels who have long anticipated a lower profile and best-in-class expandable interbody.

Global Industry Analysts Predicts the World Internet of Things (IoT) in Manufacturing Market to Reach $53.7 Billion by 2026

Retrieved on: 
Tuesday, August 31, 2021

SAN FRANCISCO, Aug. 31, 2021 /PRNewswire/ --A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Internet of Things (IoT) in Manufacturing - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, Aug. 31, 2021 /PRNewswire/ --A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Internet of Things (IoT) in Manufacturing - Global Market Trajectory & Analytics" .
  • Geographies:World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
  • The U.S. Market is Estimated at $10.6 Billion in 2021, While China is Forecast to Reach $9.4 Billion by 2026
    The Internet of Things (IoT) in Manufacturing market in the U.S. is estimated at US$10.6 Billion in the year 2021.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

Tachyum Boots Linux on Prodigy FPGA

Retrieved on: 
Tuesday, August 31, 2021

Tachyum Inc. today announced that it has successfully executed the Linux boot process on the field-programmable gate array (FPGA) prototype of its Prodigy Universal Processor, in 2 months after taking delivery of the IO motherboard from manufacturing.

Key Points: 
  • Tachyum Inc. today announced that it has successfully executed the Linux boot process on the field-programmable gate array (FPGA) prototype of its Prodigy Universal Processor, in 2 months after taking delivery of the IO motherboard from manufacturing.
  • Tachyum engineers were able to perform the Linux boot, execute a short user-mode program and shutdown the system on the fully functional FPGA emulation system.
  • Achieving a successful Linux boot in 2 months after receiving the FPGA IO motherboard prototype is a huge milestone.
  • As the worlds first universal processor, Prodigy runs legacy x86, ARM and RISC-V binaries in addition to its native Prodigy code.